anovulatory infertility
Women's health · 2012–2022
6decisions
4medicines
2carried consumer input
0individual submissions
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| human menopausal gonadotrophin Treatment of infertility in anovulatory infertility (including polycystic ovarian disease) unresponsive to clomiphene citrate, and for controlled ovarian… | Jul 2022 | Recommended with restriction | none received |
| follitropin alfa Treatment of anovulatory infertility in women unresponsive to clomiphene citrate, controlled ovarian hyperstimulation in women undergoing assisted reproductive… | Jul 2021 | Recommended with restriction | input received IVF Directors Group |
| chorionic gonadotrophin Treatment of anovulatory infertility, infertility, combined deficiency of human growth hormone and gonadotrophins, hypogonadism or delayed puberty, and… | Mar 2017 | Recommended | none received |
| human menopausal gonadotrophin Treatment of anovulatory infertility in women who have failed to ovulate or conceive on clomiphene citrate and/or gonadorelin. | Mar 2016 | Not recommended | none received |
| gonadotrophin, menopausal human, highly purified Anovulatory infertility in women who have failed to ovulate or conceive on clomiphene citrate and/or gonadorelin. | Nov 2016 | Not recommended | input received |
| human menopausal gonadotrophin For the treatment of anovulatory infertility, including polycystic ovarian disease (PCOD), in women who have been unresponsive to treatment with clomiphene… | Mar 2012 | Recommended with restriction | unclear |
Who spoke
IVF Directors Group
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 2 of 5 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.